Paul Tudor Jones’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,800
Closed -$436K 3616
2026
Q1
$436K Buy
19,800
+8,400
+74% +$146K ﹤0.01% 2900
2025
Q4
$134K Sell
11,400
-5,000
-30% -$64.2K ﹤0.01% 3357
2025
Q3
$260K Sell
16,400
-5,200
-24% -$75.4K ﹤0.01% 3066
2025
Q2
$247K Buy
21,600
+2,800
+15% +$31.6K ﹤0.01% 2989
2025
Q1
$254K Buy
+18,800
New +$312K ﹤0.01% 2707
2024
Q1
Sell
-6,400
Closed -$202K 2272
2023
Q4
$202K Buy
+6,400
New +$174K ﹤0.01% 2202
2023
Q3
Sell
-31,200
Closed -$1.15M 2330
2023
Q2
$1.15M Buy
+31,200
New +$952K 0.01% 1236
2023
Q1
Sell
-9,300
Closed -$284K 2454
2022
Q4
$284K Buy
+9,300
New +$279K 0.01% 1939
2022
Q1
Sell
-12,500
Closed -$418K 2070
2021
Q4
$418K Sell
12,500
-300
-2% -$9.35K 0.01% 1598
2021
Q3
$374K Buy
+12,800
New +$414K 0.01% 1862

Other funds holding CC

Paul Tudor Jones's CC Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Chemours (CC) in Q2 2026: 239,835 shares worth $4.92M. The stake represents 0.01% of the portfolio and ranks #1292 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in CC as recently as Q2 2025.

Paul Tudor Jones first reported a position in CC in Q1 2016 and has held it in 25 quarters since. The position peaked at $11.7M in Q4 2023. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Paul Tudor Jones held 239,835 shares of Chemours worth $4.92M as of Q2 2026.
  • Chemours was a new Paul Tudor Jones position in Q2 2026.
  • Chemours made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1292 holding.
  • Paul Tudor Jones first reported a position in Chemours in Q1 2016 and has held it in 25 quarters since.
  • Paul Tudor Jones's Chemours position peaked at $11.7M in Q4 2023.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.